PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre de référence pour la mucoviscidose, Cliniques universitaires Saint-Luc, Brussels, Belgium; Department of Pediatrics, Cliniques universitaires Saint-Luc, Brussels, Belgium.\', \'Department of medical biology and microbiology, Cliniques universitaires Saint-Luc, Brussels, Belgium.\', \'Centre de référence pour la mucoviscidose, Cliniques universitaires Saint-Luc, Brussels, Belgium.\', \'Centre de référence pour la mucoviscidose, Cliniques universitaires Saint-Luc, Brussels, Belgium; Department of Pneumology, Cliniques universitaires Saint-Luc, Brussels, Belgium; Pole of Pneumology, ENT and Dermatology, Institute of Experimental & Clinical Research, Université catholique de Louvain (UCLouvain), Brussels, Belgium. Electronic address: sophie.gohy@uclouvain.be.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1569-1993(20)30821-310.1016/j.jcf.2020.08.005
?:doi
?:hasPublicationType
?:journal
  • Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
is ?:pmid of
?:pmid
?:pmid
  • 32828701
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all